The Bone Graft Market size was valued at US$ 4.46 Billion in 2022 and is projected to reach US$ 6.69 Billion by 2030, with a growing CAGR of 5.2% over the forecast period 2023-2030.
Bone Graft is implantable material, which advances bone mending, bone arrangement, and bony remaking due to its osteoconductive, osteogenic, and osteoinductive properties. They are utilized in sports, injury, plastic, facial, and spinal medical procedures. What's more, they can be utilized to make up for shortfalls if there should be an occurrence of nonattendance of bones or help in the arrangement of underlying dependability. Bone graft is surgery for supplanting a missing or abandoned bone with a material (bone join) from a patient's own body, corpse, creature, or an alternate individual. It tracks down its application in injury mending, complex crack treatment, and others.
Get more information on Bone Graft Market - Request Sample Report
The development of the worldwide bone graft and substitutes market is driven by elements, for example, ascend in the occurrence of outer muscle problems, improvement of biocompatible engineered bone graft, mechanical headways in the clinical field prompting a shift from autograft to allograft, and expansion sought after for dental bone graft. In any case, greater expenses of medical procedures and moral issues connected with bone joining methodology are expected to restrict bone graft and substitute market development. On the other hand, expansion in the focal point of central participants toward R&D exercises in bone graft and their substitutes and upsurge sought after for muscular techniques among the geriatric populace is supposed to give worthwhile open doors to the market players later on.
Extending pace of road wounds and joint issues
The pace of street wounds is on the ascent. For example, as per the WHO, around 20 to 50 million individuals experience non-lethal wounds, and roughly 1.35 million individuals kick the bucket because of street mishaps consistently. In addition, as per the National Trauma Institute, 2014, the financial weight because of injury cases has expanded to USD 671 billion, including medical care expenses and lost efficiency costs. Bone graft has various applications in fixing wounds and infections. It could be utilized on account of different or complex cracks or those that don't recuperate well after starting treatment. It is likewise utilized for a combination that assists two bones with recuperating in a sick joint. The Combination is most frequently done on the spine.
Improvement of biocompatible produced bone associations
Extended interest in dental bone associations
The Significant expense of the medical procedures
High interest in the muscular consideration area
Thorough and practically identical appraisals of well-being spending in every nation are a critical contribution to well-being strategy and in proper order. They are important to help the accomplishments of public and global wellbeing objectives. On February 20, 2019, the WHO delivered another report on worldwide well-being consumption, as indicated by which the worldwide spending on well-being in low-and center pay nations expanded by 6%and in top-level salary nations by 4%. State-run administrations represent under 40%of essential medical services spending. Many organizations are grafting the area in light of the great market and an open door. Existing players are burning through huge amounts of cash on research and improvement to add cutting-edge innovations to their portfolios and keep up with their piece of the pie.
The bone graft substitute market is increasing and is supposed to keep developing consistently during the review time frame. This is because of the developing commitment of existing players to make the item more powerful. The store network investigation for the bone graft substitute market contains five significant parts, which begin with the examination and item advancement followed by assembling the items, dissemination, deals, and finishes with post-deals organizations.
The key market players center around integrating developments in their ongoing methods to keep any errors under control. For example, in July 2020, Baxter International Inc. declared the US Food and Drug Administration (FDA) freedom of Altapore Shape Bioactive Bone Graft to its cutting-edge bone graft substitute product offering.
The general effect of the COVID-19 pandemic is probably going to remain genuinely negative for clinical gadget organizations in the bone graft and substitute industry. Organizations are confronting a put-off, inferable from the lockdown, which has prompted interruptions in the store network exercises across the globe. Also, vital participants in the business are confronting issues as to the accessibility of human assets for assembling bone grafts and substitutes at creation offices. Also, end clients, for example, clinics and centers announced a decrease in quiet visits because of the lockdown limitations carried out around the world. In any case, this present circumstance is supposed to improve as the government has begun loosening up standards all over the planet for continuing business exercises. Besides, the interest in bone unions and substitutes is probably going to increment post-recommencing elective medical procedures and techniques soon.
The bone graft substitute market has been partitioned in view of item type and application.
By Product Type
Allograft
Allografts are the legitimate swap for autografts. Allografts are taken from people other than the one getting the join. For the most part, taken from corpses have given their bone so it very well may be utilized for individuals who are alive and out of luck; it is regularly obtained from a bone bank. However, there is a high gamble of sickness transmission while involving these allografts for bone joining as the body from which it is taken might be conveying the infection. Thus, these bones are profoundly handled and disinfected to lessen the possibility of sickness transmission. Allografts are portioned into machine allografts and Demineralized Bone Matrix (DB).
Bone Graft Substitute
The bone graft substitute is an engineered inorganic or naturally natural mix, which invigorates bone recuperating and fills bone deformities. It is additionally ordered into Bone Morphogenic Proteins (BMP) and engineered bone grafts.BMP are normally happening proteins found in the human body. These proteins animate the development of the bones normally in the human body. Various kinds of BMPs are found in the body. In any case, scientists have been zeroing in principally on the BMP-2 and BMP-7. These BMPs are significantly utilized in spinal combination treatment and are said to have an improved outcome than the other bone substitutes.
Cell-based Matrices
Progresses in the field of foundational microorganism innovation have animated the turn of events and expanded the utilization of allogeneic bone grafts containing live Mesenchymal Stem Cells (MSCs), otherwise called Cellular Bone Matrices (CBMs). Bone marrow and fat tissue are two of the primary wellsprings of these phones. It is assessed that CBMs include more than 17% of every bone graft and bone join substitute utilized.
By Application
The bone graft substitute market, by application, is sub-segmented into the dental, foot, and lower leg, joint recreation, long bone, and spinal combination. The spinal combination section overwhelmed the market in 2022. The spinal combination fragment is projected to be the quickest developing portion during the review time frame.
Spinal Fusion
The Spinal combination is a critical methodology wherein a strong scaffold is shaped between two vertebral spines to stop the development in that segment. It is vital to comprehend that bone grafts don't straightforwardly mend the spinal misery or do the spinal combination. In any case, bone graft establishes a climate for that strong extension to frame. Bone graft gives an establishment to the spine and permits the body to recover the bone and circuit the segment of the spine.
Joint Reconstruction
Joint recreation is a surgery used to fix and re-establish the full capacity of a given joint. It is one more muscular region where the utilization of bone join substitutes is unnecessarily finished. With the rising age, the human joints will generally become frail and are harmed in any event, during the littlest of mishaps or wounds. Also, there are sure situations, for example, sports injuries and vehicular mishaps, where the joints are removed or harmed.
Long Bone
Long bones are basically harmed because of extreme wounds, mishaps, injuries, or illnesses. They are intended to be solid and stable to adapt to the heaviness of the body. Engineered bone substitutes are not utilized for the remaking of long bones as they need development factors and other osteogenic properties. Autogenous unions or allografts are fundamentally utilized for long bone recreation.
Dental
Bone joining is essentially utilized in dental inserts to fix harmed or missing teeth. High level capacity and improved tasteful worth are a portion of the fundamental requirements for patients in this day and age. Bone grafts are utilized in dental reclamations as there is a prerequisite of enough bone volume and prevalent biologic properties for the right position of the dental inserts and the ideal results. Dental science has been progressively involving bone grafts alternative for supportive techniques.
Foot & Ankle
Bone grafting is a typical system for foot and lower leg-related medical procedures. Foot and lower leg medical procedures are critical as the patients having an ordinary existence are subject to whether they will actually want to walk in the future with no aggravation or imperfection. By and large, autografts were the favored decision, however because of drawbacks, for example, site dismalness, interest is ascending in utilizing bone join substitutes all things being equal. Engineered bone grafts, for example, calcium sulfate permit complex shapes to be etched and, surprisingly, percutaneous infusions to be performed. Calcium sulfate is a manufactured bone graft that permits complex shapes to be etched and even works with percutaneous infusions.
By Product Type
Allograft
Bone Graft Substitute
Cell-based Matrices
By Application
Spinal Fusion
Joint Reconstruction
Long Bone
Dental
Foot Ankle
Others
.png)
North America overwhelmed the market with more than 40.0% portion of the worldwide income in 2021. Developing mindfulness connected with the economically available imaginative items, the openness of an advanced medical care structure, and higher medical services use of 16.9% in 2018 is the significant angles adding to the local market development. The market in the U.S. is driving the North American as well as worldwide market by creating the most extreme interest for bone grafts and substitutes on account of the developing number of injury-related wounds as well as instances of muscular infection.
Asia Pacific is assessed to observe rewarding development during the gauge time frame. This development can be ascribed to rising clinical the travel industry and ideal government drives. Then again, tough administrative rules limit the reception in a couple of countries. For example, in South Korea, the item must be supported prior to advertising by the Korean Food and Drug Administration (KFDA). In Australia, the items are directed by the Therapeutic Goods Administration (TGA). The tough administrative viewpoint in Japan confines the passage of unfamiliar players into the country. However, with the most recent endorsement of DBM in Japan in 2019, the allograft market is set to keep worthwhile development in the Asia Pacific over the course of the following 10 years.
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The major players are Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Corporation, Xtant Medical Holdings Inc., Zimmer Biomet Holdings Inc. and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2022 | US$ 4.46 Billion |
| Market Size by 2030 | US$ 6.69 Billion |
| CAGR | CAGR of 5.2% From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product Type (Allograft, Bone Graft Substitute, Cell-based Matrices) • By Application (Spinal Fusion, Joint Reconstruction, Long Bone, Dental, Foot & Ankle, others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Arthrex Inc., Baxter International Inc., Integra Life Sciences Holdings Corporation, Johnson & Johnson (DePuy Synthes), Medtronic Plc., Musculoskeletal Transplant Foundation, NuVasive Inc., Stryker Corporation, Xtant Medical Holdings Inc., Zimmer Biomet Holdings Inc. |
| DRIVING FACTORS | • Extending pace of road wounds and joint issues |
| Restraints | • The expense of a bone graft fluctuates generally relying upon the circumstance and the state of the patient. For instance, basic bone uniting for dental purposes utilizing engineered bone will cost anyplace from USD 300 to USD 800 for a solitary embed district. At the point when a patient's bone material is obtained from various pieces of the body for a bone graft activity, hospitalization is required, which builds the expense. This type of graft additionally requires the administration of a muscular specialist and an anesthesiologist, bringing about a dental bone graft cost of USD 2,500 to USD 3,500. • Chance and entanglements from bone graft methods |
Ans:- The bone graft Market was valued at USD 4.46 Bn by 2022.
Ans: The Bone Graft Market is growing at a CAGR of 5.2% over the forecast period 2023-2030.
North America was the greatest revenue contributor in the bone graft and alternatives market.
The forecast period for the bone graft market is 2022 to 2028.
. Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries are the stake holder of this report
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Bone Graft Market Segmentation, by product type
8.1 Allograft
8.2 Bone Graft Substitute
8.3 Cell-based Matrices
9. Bone Graft Market Segmentation, By application
9.1 Excavation and mining
9.2 Lifting and material handling
9.3 Earth moving
9.4 Transportation
9.5 Others
10. Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 USA
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 The Netherlands
10.3.7 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 South Korea
10.4.3 China
10.4.4 India
10.4.5 Australia
10.4.6 Rest of Asia-Pacific
10.5 The Middle East & Africa
10.5.1 Israel
10.5.2 UAE
10.5.3 South Africa
10.5.4 Rest
10.6 Latin America
10.6.1 Brazil
10.6.2 Argentina
10.6.3 Rest of Latin America
11. Company Profiles
11.1 MEDTRONIC PLC
11.1.1 Financial
11.1.2 Products/ Services Offered
11.1.3 SWOT Analysis
11.1.4 The SNS view
11.2 Arthrex Inc.
11.3 Baxter International Inc.
11.4 Integra Life Sciences Holdings Corporation
11.5 Johnson & Johnson (DePuy Synthes)
11.6 Musculoskeletal Transplant Foundation
11.7 NuVasive Inc.
11.8 Stryker Corporation
11.9 Xtant Medical Holdings Inc.
11.10 Zimmer Biomet Holdings, Inc.
12. Competitive Landscape
12.1 Competitive Benchmark
12.2 Market Share Analysis
12.3 Recent Developments
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Neuroendoscopy Market size is projected to grow from $151.07 million in 2023 to $237.05 million by 2031, at a CAGR of 5.8% during the forecast period.
The Biosimulation Market Size was valued at USD 2.4 billion in 2023 and is expected to reach USD 8.4 billion by 2031, and grow at a CAGR of 17.0% over the forecast period 2024-2031.
The Anxiety Disorder Treatment Market size is projected to grow from $12 billion in 2022 to $15.89 billion by 2030, at a CAGR of 3.95% during the forecast period.
In 2023, The Coronary Stent Market size amounted to USD 9.63 Billion & is estimated to reach USD 12.49 Billion by 2031 and increase at a compound annual growth rate of 3.3% between 2024 and 2031.
The Bone Morphogenetic Protein Market size was estimated USD 460.1 million in 2022 and is expected to reach USD 624.8 million by 2030 at a CAGR of 3.9% during the forecast period of 2023-2030.
The Veterinary Imaging Market size was USD 1.85 Billion in 2022 and is expected to Reach USD 3.09 Billion by 2030 and grow at a CAGR of 6.64% over the forecast period of 2023-2030.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
